Geode Capital Management, LLC Zosano Pharma Corp Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.28 - $7.63 $252,088 - $6.87 Million
-900,316 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$4.2 - $18.55 $3.78 Million - $16.7 Million
900,316 New
900,316 $203,000

Others Institutions Holding ZSANQ

# of Institutions
1
Shares Held
28
Call Options Held
0
Put Options Held
0
View Full List

About Zosano Pharma Corp

ZSANQ Quotes by TradingView
  • Ticker ZSANQ
  • Exchange OTC
  • Shares Outstandng 4,902,260
  • Description
  • Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The ...
More about ZSANQ
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email